COVID-19 and vaccination during pregnancy: a systematic analysis using Korea National Health Insurance claims data
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Objective: This study systematically analyzed coronavirus disease 2019 (COVID-19) and vaccination details during pregnancy by using the national health insurance claims data. Methods: Population-based retrospective cohort data of 12,399,065 women aged 15-49 years were obtained from the Korea National Health Insurance Service claims database between 2019 and 2021. Univariate analysis was performed to compare the obstetric outcomes of pregnant women (ICD-10 O00-O94) and their newborns (ICD-10 P00-P96) with and without COVID-19. Univariate analysis was also performed to compare the age and obstetric outcomes of pregnant women receiving different types of vaccines. Results: The percentage of pregnant women with COVID-19 during pregnancy was 0.11%. Some obstetric outcomes of pregnant women with COVID-19, including the rates of preterm birth or cesarean delivery, were significantly better than those of pregnant women without COVID-19. The rate of miscarriage was higher in pregnant women with COVID-19 than without COVID-19. However, the outcomes of newborns of women with and without COVID-19 were not significantly different. Regarding vaccination type, obstetric outcomes of pregnant women appeared to be worse with the viral vector vaccine than with the mRNA vaccine. Conclusion: To the best of our knowledge, this is the first study to systematically analyze COVID-19 and vaccination details during pregnancy using the national health insurance claims data in Korea. The obstetric outcomes in pregnant women with and without COVID-19 and their newborns were similar.
Abstract
Objective: This study systematically analyzed coronavirus disease 2019 (COVID-19) and vaccination details during pregnancy by using the national health insurance claims data. Methods: Population-based retrospective cohort data of 12,399,065 women aged 15-49 years were obtained from the Korea National Health Insurance Service claims database between 2019 and 2021. Univariate analysis was performed to compare the obstetric outcomes of pregnant women (ICD-10 O00-O94) and their newborns (ICD-10 P00-P96) with and without COVID-19. Univariate analysis was also performed to compare the age and obstetric outcomes of pregnant women receiving different types of vaccines. Results: The percentage of pregnant women with COVID-19 during pregnancy was 0.11%. Some obstetric outcomes of pregnant women with COVID-19, including the rates of preterm birth or cesarean delivery, were significantly better than those of pregnant women without COVID-19. The rate of miscarriage was higher in pregnant women with COVID-19 than without COVID-19. However, the outcomes of newborns of women with and without COVID-19 were not significantly different. Regarding vaccination type, obstetric outcomes of pregnant women appeared to be worse with the viral vector vaccine than with the mRNA vaccine. Conclusion: To the best of our knowledge, this is the first study to systematically analyze COVID-19 and vaccination details during pregnancy using the national health insurance claims data in Korea. The obstetric outcomes in pregnant women with and without COVID-19 and their newborns were similar.
참고문헌 (31)
- Wang D, "Clinical characteristics of 138 hospitalized patients with 2019novel coronavirus-infected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
- Yuen KS, "SARS-CoV-2and COVID-19 : the most important research questions", Cell Biosci, 10, pp.40~ (2020)
- Wan S, "Clinical features and treatment of COVID-19 patients in northeast Chongqing", J Med Virol, 92, pp.797~806 (2020)
- Munn MB, "Pneumonia as a complication of pregnancy", J Matern Fetal Med, 8, pp.151~154 (1999)
- Goodnight WH, "Pneumonia in pregnancy", Crit Care Med, 33(10 Suppl), pp.S390~S397 (2005)
- Amirian A, "Neonatal outcome among pregnant women with COVID-19 : a systematic review and meta-analysis", J Matern Fetal Neonatal Med, 4, pp.1~15 (2022)
- 배진곤, "A case of delivery of a pregnant woman with COVID-19 infection in Daegu, Korea", Obstetrics & Gynecology Science, 63(6), pp.745~749 (2020), 대한산부인과학회[DOI]
- "COVID-19 vaccines while pregnant or breastfeeding" (2021)[URL]
- "The American College of Obstetrics and Gynecology" (2021)[URL]
- 김혜영, "Statistical notes for clinical researchers: Chi-squared test and Fisher's exact test", Restorative Dentistry and Endodontics, 42(2), pp.152~155 (2017), 대한치과보존학회
- "United states centers for disease control and prevention. Investigating the impact of COVID-19 during pregnancy" (2021)[URL]
- Jamieson DJ, "An update on COVID-19and pregnancy", Am J Obstet Gynecol, 226, pp.177~186 (2021)
- Smith V, "Maternal and neonatal outcomes associated with COVID-19 infection : a systematic review", PLoS One, 15, pp.e0234187~ (2020)
- Yan J, "Coronavirus disease 2019 in pregnant women : a report based on 116 cases", Am J Obstet Gynecol, 223, pp.111.e1~111.e14 (2020)
- Bellos I, "Maternal and perinatal outcomes in pregnant women infected by SARS-CoV-2 : a meta-analysis", Eur J Obstet Gynecol Reprod Biol, 256, pp.194~204 (2021)
- Cardona-Pérez JA, "Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild", moderate symptoms : results from universal screening in a tertiary care center in Mexico City, Mexico, 2021, pp.16, e0249584~
- Akhtar H, "COVID-19(SARS-CoV-2)infection in pregnancy : a systematic review", Gynecol Obstet Invest, 85, pp.295~306 (2020)
- Abedzadeh-Kalahroudi M, "Clinical and obstetric characteristics of pregnant women with covid-19 : a case series study on 26 patients", Taiwan J Obstet Gynecol, 60, pp.458~462 (2021)
- de Medeiros KS, "Consequences and implications of the coronavirus disease(COVID-19)on pregnancy and newborns : a comprehensive systematic review and meta-analysis", Int J Gynaecol Obstet, 156, pp.394~405 (2022)
- Trippella G, "COVID-19 in pregnant women and neonates : a systematic review of the literature with quality assessment of the studies", Pathogens, 9, pp.485~ (2020)
- Selvaratnam RJ, "Increasing obstetric intervention for fetal growth restriction is shifting birthweight centiles : a retrospective cohort study", BJOG, 127, pp.1074~1080 (2020)
- Philip RK, "Unprecedented reduction in births of very low birthweight(VLBW)and extremely low birthweight(ELBW)infants during the COVID-19 lockdown in Ireland : a ‘natural experiment’ allowing analysis of data from the prior two decades", BMJ Glob Health, 5, pp.e003075~ (2020)
- Bian Z, "Are COVID-19 mitigation measures reducing preterm birth rate in China?", BMJ Glob Health, 6, pp.e006359~ (2021)
- "COVID-19 breifing" (2021)[URL]
- Lee H, "Power of universal health coverage in the era of COVID-19 : a nationwide observational study", Lancet Reg Health West Pac, 7, pp.100088~ (2021)
- Celewicz A, "Pregnancy as a risk factor of severe COVID-19", J Clin Med, 10, pp.5458~ (2021)
- Linder N, "Birth trauma--risk factors and short-term neonatal outcome", J Matern Fetal Neonatal Med, 26, pp.1491~1495 (2013)
- Moczygemba CK, "Route of delivery and neonatal birth trauma", Am J Obstet Gynecol, 202, pp.361. e1~361. e6 (2010)
- Leik NKO, "Covid-19 vaccine and its consequences in pregnancy: brief review", Ann Med Surg(Lond), 72, pp.103103~ (2021)
- Lipkind HS, "Receipt of COVID-19vaccine during pregnancy and preterm or small-forgestational-age at birth-eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021", MMWR Morb Mortal Wkly Rep, 71, pp.26~30 (2022)
- Shay DK, "Safety monitoring of the Janssen(Johnson & Johnson)COVID-19 vaccine-United States, March-April 2021", MMWR Morb Mortal Wkly Rep, 70, pp.680~684 (2021)